Trial intelligence / Profile preview

Salsalate effects on glucose metabolism in diabetes

IRCT138709011465N1Phase 3Completed

Sponsor
Isfahan Endocrine and Metabolism Research Center
Start
Aug 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Amigesic in diabetes mellitus (DM), sponsored by Isfahan Endocrine and Metabolism Research Center. Started Aug 2008; status: completed.

02

Drugs

Amigesic
03

Conditions

diabetes mellitus (DM)

Beyond the preview

Go deeper on IRCT138709011465N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT138709011465N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call